Twitter Facebook LinkedIn YouTube Instagram
Benaroya Research Institute is committed to fighting the more than 80 autoimmune diseases.
Scientists at BRI continue to look for better drugs and therapies as well as ways to eliminate multiple sclerosis.
BRI scientists have learned there are multitudes of different immune system cell types, and few are exactly alike.
Over the last few years, several unique and pioneering technologies at BRI have been combined to create a “pipeline” approach to find and study rare disease-associated cells.
The history of how BRI's current home at 1201 Ninth Ave. came to be.
Clinical studies are medical research studies in which people participate as volunteers. And they are one of the most valuable ways you can contribute to research.
Multiple sclerosis (MS) affects more than a million people worldwide including 15,000 in the Northwest.
One of the nation’s greatest research treasures was developed at Benaroya Research Institute at Virginia Mason (BRI) and i
This blog does not provide medical advice, nor is it a substitutefor professional medical advice, diagnosis or treatment.
© 2020 Benaroya Research Institute at Virginia Mason. 1201 Ninth Avenue, Seattle, WA 98101-2795
Your donation to the COVID-19 Rapid Response Fund will directly support urgent research into the immune system response to the virus. With your help, we can get to answers faster to bring an end to this public health crisis.
No thanks, close this window